Effect of reduced-dose vs high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: a randomized clinical trial

S Furuta, D Nakagomi, Y Kobayashi, M Hiraguri… - Jama, 2021 - jamanetwork.com
Importance The current standard induction therapy for antineutrophil cytoplasm antibody
(ANCA)–associated vasculitis is the combination of high-dose glucocorticoids and …

Prediction of therapeutic responses to tocilizumab in patients with rheumatoid arthritis: biomarkers identified by analysis of gene expression in peripheral blood …

Y Sanayama, K Ikeda, Y Saito, S Kagami… - Arthritis & …, 2014 - Wiley Online Library
Objective The aim of this prospective multicenter study was to identify biomarkers that can
be used to predict therapeutic responses to tocilizumab in patients with rheumatoid arthritis …

Longterm outcomes of 188 Japanese patients with eosinophilic granulomatosis with polyangiitis

A Saku, S Furuta, M Hiraguri, K Ikeda… - The Journal of …, 2018 - jrheum.org
Objective. Patients with eosinophilic granulomatosis with polyangiitis (EGPA) frequently
experience relapses, which lead to cumulative organ damage. In this retrospective …

Low-dose glucocorticoids plus rituximab versus high-dose glucocorticoids plus rituximab for remission induction in ANCA-associated vasculitis (LoVAS): protocol for a …

S Furuta, T Sugiyama, T Umibe, Y Kaneko, K Amano… - BMJ open, 2017 - bmjopen.bmj.com
Introduction Antineutrophil cytoplasm antibody-associated vasculitis (AAV) is a form of
systemic vasculitis. The current standard induction therapy with the combination of high …

[HTML][HTML] Prognostic factors of Pneumocystis pneumonia in patients with systemic autoimmune diseases

T Kageyama, S Furuta, K Ikeda, S Kagami… - PloS one, 2019 - journals.plos.org
Objective Pneumocystis pneumonia (PCP) is one of the most common opportunistic
infections. In systemic autoimmune disease patients receiving immunosuppressive …

Short-term and long-term outcomes of patients with anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis

T Ida, S Furuta, M Fujiwara, M Hiraguri, K Hirose… - …, 2024 - academic.oup.com
Objectives Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive
dermatomyositis (MDA5-DM) is a subtype of dermatomyositis characterized by frequent …

[HTML][HTML] Severity and diurnal improvement of morning stiffness independently associate with tenosynovitis in patients with rheumatoid arthritis

Y Kobayashi, K Ikeda, T Nakamura, M Yamagata… - PLoS …, 2016 - journals.plos.org
Background and objectives Although morning stiffness has long been recognized as a
characteristic feature of rheumatoid arthritis (RA), it is no more included in the 2010 …

Effect of a Selective Thromboxane A2 Receptor Antagonist BAY u3405 on Antigen-, Leukotriene C4- and Leukotriene D4-lnduced Bronchoconstriction in Guinea …

I Iwamoto, T Umibe, H Nakajima… - International archives of …, 1995 - karger.com
We studied the effect of a selective thromboxane (TX) A2 receptor antagonist BAY u3405 on
prostanoid-, leukotriene (LT) C4, LTD4-and antigen-induced bronchoconstriction in …

[HTML][HTML] Development of a Kidney Prognostic Score in a Japanese Cohort of Patients With Antineutrophil Cytoplasmic Autoantibody Vasculitis

R Takeda, K Takahashi, A Kronbichler… - Kidney International …, 2024 - Elsevier
Introduction Glomerulonephritis is frequent in antineutrophil cytoplasmic antibody (ANCA)-
associated vasculitis (AAV) and crucial to disease outcomes. We conducted a detailed …

Salazosulfapyridine-induced encephalopathy with symmetrical lesions in the basal ganglia and thalami

H Takahashi, S Ito, K Nagumo, S Kojima, T Umibe… - Internal …, 2006 - jstage.jst.go.jp
A 48-year-old woman with RA was admitted with fever, 11 days after administration of SASP
in addition to indometacin. She had not taken aspirin. On admission, her body temperature …